Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)
CNY 19.6
(0.56%)
CNY 19.6
(0.56%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 254.48 Million CNY | -8.39% |
| 2022 | 277.78 Million CNY | 38.32% |
| 2021 | 200.82 Million CNY | 32.37% |
| 2020 | 151.71 Million CNY | 22.45% |
| 2019 | 123.89 Million CNY | 15.09% |
| 2018 | 107.65 Million CNY | 21.12% |
| 2017 | 88.87 Million CNY | 9.76% |
| 2016 | 80.97 Million CNY | 29.27% |
| 2015 | 62.64 Million CNY | -9.54% |
| 2014 | 69.25 Million CNY | 28.13% |
| 2013 | 54.04 Million CNY | 58.86% |
| 2012 | 34.02 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 23.74 Million CNY | -69.22% |
| 2024 Q1 | 77.13 Million CNY | -33.0% |
| 2024 Q3 | 17.79 Million CNY | -25.04% |
| 2023 Q4 | 115.11 Million CNY | 134.34% |
| 2023 Q3 | 49.12 Million CNY | 77.83% |
| 2023 FY | 254.48 Million CNY | -8.39% |
| 2023 Q1 | 62.61 Million CNY | -57.59% |
| 2023 Q2 | 27.62 Million CNY | -55.88% |
| 2022 Q4 | 147.64 Million CNY | 206.83% |
| 2022 Q2 | 23.02 Million CNY | -60.97% |
| 2022 Q1 | 58.99 Million CNY | -48.15% |
| 2022 FY | 277.78 Million CNY | 38.32% |
| 2022 Q3 | 48.11 Million CNY | 109.01% |
| 2021 Q3 | 32.05 Million CNY | 132.92% |
| 2021 Q4 | 113.77 Million CNY | 254.93% |
| 2021 Q1 | 41.23 Million CNY | -51.32% |
| 2021 Q2 | 13.76 Million CNY | -66.62% |
| 2021 FY | 200.82 Million CNY | 32.37% |
| 2020 Q2 | 9.54 Million CNY | -70.92% |
| 2020 Q3 | 24.65 Million CNY | 158.4% |
| 2020 FY | 151.71 Million CNY | 22.45% |
| 2020 Q4 | 84.7 Million CNY | 243.63% |
| 2020 Q1 | 32.81 Million CNY | -50.95% |
| 2019 Q3 | 10.23 Million CNY | 194.94% |
| 2019 FY | 123.89 Million CNY | 15.09% |
| 2019 Q4 | 66.88 Million CNY | 553.79% |
| 2019 Q2 | 3.46 Million CNY | -91.99% |
| 2019 Q1 | 43.3 Million CNY | -9.12% |
| 2018 Q1 | 36.17 Million CNY | -5.02% |
| 2018 FY | 107.65 Million CNY | 21.12% |
| 2018 Q4 | 47.65 Million CNY | 699.54% |
| 2018 Q3 | 5.95 Million CNY | -66.64% |
| 2018 Q2 | 17.86 Million CNY | -50.61% |
| 2017 FY | 88.87 Million CNY | 9.76% |
| 2017 Q1 | 24.64 Million CNY | -35.13% |
| 2017 Q2 | 16.3 Million CNY | -33.83% |
| 2017 Q3 | 9.83 Million CNY | -39.68% |
| 2017 Q4 | 38.08 Million CNY | 287.12% |
| 2016 Q1 | 21.85 Million CNY | 0.0% |
| 2016 Q4 | 37.99 Million CNY | 516.49% |
| 2016 FY | 80.97 Million CNY | 29.27% |
| 2016 Q3 | 6.16 Million CNY | -58.8% |
| 2016 Q2 | 14.95 Million CNY | -31.57% |
| 2015 FY | 62.64 Million CNY | -9.54% |
| 2014 FY | 69.25 Million CNY | 28.13% |
| 2013 FY | 54.04 Million CNY | 58.86% |
| 2012 FY | 34.02 Million CNY | 0.0% |